Literature DB >> 1969889

Perspectives on the medical use of drugs of abuse.

D P Friedman.   

Abstract

The treatment of severe pain requires the use of potent opioid analgesic medications. Many patients with opioid sensitive pain are being undermedicated. This results in increased morbidity and needless suffering. The most important reason for this undertreatment is the fear of addiction engendered by opioids, a fear that is greatly out of proportion to the real risk. The risk of addiction is greatly overestimated in part because many people do not understand the distinctions between drug abuse and drug addiction, on the one hand, and physical dependence and tolerance, on the other. Dependence and tolerance are virtually inevitable outcomes of long-term opioid use, but they are neither sufficient to cause addiction nor the equivalent of it. Indeed, the evidence shows that only a tiny fraction of patients treated with opioids become addicted. There is little risk of addiction for those patients receiving properly administered opioids for pain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969889

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  4 in total

Review 1.  Treatment principles for the use of opioids in pain of nonmalignant origin.

Authors:  S A Schug; A F Merry; R H Acland
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  Nurses' willingness to maximize opioid analgesia for severe cancer pain, and its predictor.

Authors:  Yoon Jung Chang; Young Ho Yun; Sang Min Park; So Woo Lee; Hyeoun-Ae Park; You-Ja Ro; Bong Yul Huh
Journal:  Support Care Cancer       Date:  2005-04-13       Impact factor: 3.603

3.  Patient considerations in the use of tapentadol for moderate to severe pain.

Authors:  Nalini Vadivelu; Yili Huang; Brian Mirante; Michael Jacoby; Ferne R Braveman; Roberta L Hines; Raymond Sinatra
Journal:  Drug Healthc Patient Saf       Date:  2013-07-03

Review 4.  Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.

Authors:  Amie L Severino; Arash Shadfar; Joshua K Hakimian; Oliver Crane; Ganeev Singh; Keith Heinzerling; Wendy M Walwyn
Journal:  Front Psychiatry       Date:  2018-04-23       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.